Literature DB >> 16886192

Solubilization and dissolution of tamoxifen-hydroxybutenyl cyclodextrin complexes.

Charles M Buchanan1, Norma L Buchanan, Kevin J Edgar, Juanelle L Lambert, Jessica D Posey-Dowty, Michael G Ramsey, Michael F Wempe.   

Abstract

The solubility and dissolution of tamoxifen base and tamoxifen citrate with and without hydroxybutenyl-beta-cyclodextrin (HBenBCD) in aqueous and organic media were examined. The solubility of tamoxifen was greatly enhanced by complexation with HBenBCD; pH of the medium, and choice of buffer significantly impacted the amount of drug that could be solubilized. Different tamoxifen:HBenBCD formulations were prepared, including liquid fill capsule formulations, and their dissolution profiles were obtained. These dissolution studies demonstrated that enhanced solubilization of tamoxifen with HBenBCD was effective across a wide variety of formulation options. By complexation of tamoxifen base with HBenBCD, it was possible to obtain solubility and dissolution profiles for tamoxifen base that were essentially identical to that of tamoxifen citrate. Copyright (c) 2006 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16886192     DOI: 10.1002/jps.20710

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Miniaturized transfer models to predict the precipitation of poorly soluble weak bases upon entry into the small intestine.

Authors:  Sandra Klein; Norma L Buchanan; Charles M Buchanan
Journal:  AAPS PharmSciTech       Date:  2012-09-12       Impact factor: 3.246

Review 2.  Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs.

Authors:  Ying Lu; Kinam Park
Journal:  Int J Pharm       Date:  2012-08-25       Impact factor: 5.875

3.  Measuring selective estrogen receptor modulator (SERM)-membrane interactions with second harmonic generation.

Authors:  Grace Y Stokes; John C Conboy
Journal:  J Am Chem Soc       Date:  2014-01-21       Impact factor: 15.419

4.  Printing of small molecular medicines from the vapor phase.

Authors:  Olga Shalev; Shreya Raghavan; J Maxwell Mazzara; Nancy Senabulya; Patrick D Sinko; Elyse Fleck; Christopher Rockwell; Nicholas Simopoulos; Christina M Jones; Anna Schwendeman; Geeta Mehta; Roy Clarke; Gregory E Amidon; Max Shtein
Journal:  Nat Commun       Date:  2017-09-27       Impact factor: 14.919

5.  Porous Microparticles Containing Raloxifene Hydrochloride Tailored by Spray Freeze Drying for Solubility Enhancement.

Authors:  Seyyed Pouya Hadipour Moghaddam; Sajjad Farhat; Alireza Vatanara
Journal:  Adv Pharm Bull       Date:  2018-06-19

6.  Genetic Pharmacotherapy as an Early CNS Drug Development Strategy: Testing Glutaminase Inhibition for Schizophrenia Treatment in Adult Mice.

Authors:  Susana Mingote; Justine Masson; Celia Gellman; Gretchen M Thomsen; Chyuan-Sheng Lin; Robert J Merker; Inna Gaisler-Salomon; Yvonne Wang; Rachel Ernst; René Hen; Stephen Rayport
Journal:  Front Syst Neurosci       Date:  2016-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.